Our findings that SNPs in Hamp or Hamp regulation pathways could predict outcomes among patients with NSCLC after definitive radiotherapy have several implications for tailoring treatment, moving from “one size fits all” to individualized therapy. The gene discussed is HAMP; the disease is non-small cell lung carcinoma.